Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. | 91,940 | reported | 31 May 2024 | tx 10+774,440 |
| LogicBio Therapeutics, Inc. | 17,445 | reported | 15 Apr 2020 | tx 3+222,445 |
| Nightstar Therapeutics plc | 0 | reported | 07 Jun 2019 | tx 4+85,100−260,100 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 May 2024 | PURCHASE | Terns Pharmaceuticals, Inc. | 4,791 | 4.44 USD | |
| 23 Jan 2024 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 68,750 | 0.00 USD | |
| 23 Jan 2024 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 137,500 | 0.00 USD | deriv |
| 30 Nov 2023 | PURCHASE | Terns Pharmaceuticals, Inc. | 743 | 3.78 USD | |
| 31 May 2023 | PURCHASE | Terns Pharmaceuticals, Inc. | 9,997 | 1.41 USD | |
| 30 Nov 2022 | PURCHASE | Terns Pharmaceuticals, Inc. | 3 | 1.41 USD | |
| 01 Feb 2023 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 360,000 | 0.00 USD | deriv |
| 31 May 2022 | PURCHASE | Terns Pharmaceuticals, Inc. | 7,656 | 1.47 USD | |
| 26 Jan 2022 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 65,000 | 0.00 USD | deriv |
| 28 Sept 2021 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 120,000 | 0.00 USD | deriv |
| 15 Apr 2020 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 17,445 | 0.00 USD | deriv |
| 11 Feb 2020 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 95,000 | 0.00 USD | deriv |
| 11 Dec 2019 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 110,000 | 0.00 USD | deriv |
| 07 Jun 2019 | OTHER | Nightstar Therapeutics plc | 15,000 | 11.26 USD | deriv |
| 07 Jun 2019 | OTHER | Nightstar Therapeutics plc | 85,100 | 10.76 USD | deriv |
| 07 Jun 2019 | OTHER | Nightstar Therapeutics plc | 160,000 | 2.72 USD | deriv |
| 22 Jan 2019 | GRANT_AWARD | Nightstar Therapeutics plc | 85,100 | 0.00 USD | deriv |